药物对比
Rosiglitazone vs Troglitazone
Rosiglitazone vs Troglitazone：治疗2型糖尿病的TZD类药物。Troglitazone因肝衰竭已被撤市。Rosiglitazone仍在使用，但存在心脏风险。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when reviewing the safety history and market status of older thiazolidinedione drugs for type 2 diabetes.
结论
Troglitazone is unavailable due to liver toxicity while Rosiglitazone is accessible yet limited by heart failure and ischemia risks, so neither is preferred.
全部药物对比